Redefine 3 (4942)

This is a study to observe the effects of CagriSema on heart disease in people living with obesity, and diseases of the heart and blood vessels.
Clinical Description:
This study will evaluate the effects of CagriSema on cardiovascular events in people living with obesity and cardiovascular disease. The participants with either get CagriSema or Placebo.
Target Age/Sex:
Male & Female, age 55 years or above BMI of >30 with established cardiac disease
Participants will receive at no cost: study product, study materials and study-specific procedures.
Study Length:
Approximately 3 Years
Information Request

Information Request

To request additional information please call 208-522-6005 or email or complete the form below.